Assenagon Asset Management S.A. Aclaris Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

$54.8 Billion
Q1 2025

A detailed history of Assenagon Asset Management S.A. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 681,553 shares of ACRS stock, worth $858,756. This represents 0.0% of its overall portfolio holdings.

Number of Shares

681,553

Previous 397,362 71.52%

Holding current value

$858,756

Previous $985,000 5.79%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$1.53 - $2.6 $434,812 - $738,896	284,191 Added 71.52%	681,553 $1.04 Million
Q4 2024 Jan 14, 2025	BUY	$1.15 - $4.59 $243,322 - $971,175	211,585 Added 113.89%	397,362 $985,000
Q3 2024 Oct 23, 2024	BUY	$1.12 - $1.4 $208,070 - $260,087	185,777 New	185,777 $209,000
Q3 2023 Nov 06, 2023	BUY	$6.56 - $10.95 $330,007 - $550,850	50,306 Added 7.9%	687,135 $4.71 Million
Q2 2023 Jul 25, 2023	BUY	$7.89 - $10.64 $1.66 Million - $2.25 Million	211,001 Added 49.55%	636,829 $6.6 Million
Q1 2023 Apr 18, 2023	BUY	$7.07 - $17.95 $1.63 Million - $4.14 Million	230,905 Added 118.46%	425,828 $3.44 Million
Q3 2022 Oct 27, 2022	SELL	$13.07 - $18.22 $1.28 Million - $1.79 Million	-98,122 Reduced 33.48%	194,923 $3.07 Million
Q2 2022 Jul 27, 2022	SELL	$10.16 - $17.08 $2.18 Million - $3.66 Million	-214,390 Reduced 42.25%	293,045 $4.09 Million
Q1 2022 Apr 25, 2022	BUY	$9.74 - $17.92 $4.94 Million - $9.09 Million	507,435 New	507,435 $8.75 Million
Q4 2021 Feb 01, 2022	SELL	$12.27 - $18.49 $5.81 Million - $8.75 Million	-473,365 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$13.38 - $18.8 $1.38 Million - $1.95 Million	-103,507 Reduced 17.94%	473,365 $8.52 Million
Q2 2021 Jul 15, 2021	BUY	$17.08 - $29.6 $9.5 Million - $16.5 Million	556,283 Added 2701.85%	576,872 $10.1 Million
Q1 2021 Apr 26, 2021	BUY	$5.86 - $27.73 $120,651 - $570,932	20,589 New	20,589 $519,000
Q3 2019 Oct 16, 2019	SELL	$0.79 - $2.47 $65,494 - $204,775	-82,905 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$2.13 - $7.06 $176,587 - $585,309	82,905 New	82,905 $182,000
Q1 2019 Apr 26, 2019	SELL	$5.63 - $7.84 $681,291 - $948,726	-121,011 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$6.3 - $15.4 $762,369 - $1.86 Million	121,011 New	121,011 $894,000

Others Institutions Holding ACRS

# of Institutions

112

Shares Held

92.9M

Call Options Held

35.4K

Put Options Held

32K

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $84M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Aclaris Therapeutics, Inc. Transaction History